Weak China demand weighs on Illumina's sales
Illumina’s sales dropped in the second quarter, dragged down by weak demand in China and the company shipping fewer of its mid-throughput DNA sequencers than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.